Cargando…

Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions

Interactions between different cell types are critical for a plethora of biological processes, such as the immune response. We recently developed a novel technology, called LIPSTIC (labeling of immune partnership by SorTagging intercellular contacts), that allows for identifying cells undergoing spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Alberti, Dafne, Guarniero, Michelle, Maciola, Agnieszka K., Dotta, Enrico, Pasqual, Giulia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613713/
https://www.ncbi.nlm.nih.gov/pubmed/34870906
http://dx.doi.org/10.1002/cpz1.311
_version_ 1783605514851057664
author Alberti, Dafne
Guarniero, Michelle
Maciola, Agnieszka K.
Dotta, Enrico
Pasqual, Giulia
author_facet Alberti, Dafne
Guarniero, Michelle
Maciola, Agnieszka K.
Dotta, Enrico
Pasqual, Giulia
author_sort Alberti, Dafne
collection PubMed
description Interactions between different cell types are critical for a plethora of biological processes, such as the immune response. We recently developed a novel technology, called LIPSTIC (labeling of immune partnership by SorTagging intercellular contacts), that allows for identifying cells undergoing specific interactions thanks to an enzymatic labeling reaction. Our work demonstrated the use of this technology to monitor interactions between immune cells, both in vitro and in vivo, by the genetic engineering of CD40 and CD40L, an essential costimulatory axis between antigen-presenting cells and T cells. Here we describe protocols to design novel LIPSTIC-engineered ligand and receptor pairs, clone constructs into retroviral expression vector, perform their initial validation, and use them to measure interactions ex vivo. This information will be useful to investigators interested in exploiting the LIPSTIC technology to track their favorite immune interaction. Basic Protocol 1: Design of LIPSTIC-engineered ligand and receptor pairs Basic Protocol 2: Cloning of LIPSTIC-engineered ligand and receptor pairs Basic Protocol 3: Validation of LIPSTIC-engineered ligand and receptor pairs in 293T cells Basic Protocol 4: Measuring interaction with LIPSTIC in immune cells ex vivo
format Online
Article
Text
id pubmed-7613713
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-76137132022-10-15 Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions Alberti, Dafne Guarniero, Michelle Maciola, Agnieszka K. Dotta, Enrico Pasqual, Giulia Curr Protoc Article Interactions between different cell types are critical for a plethora of biological processes, such as the immune response. We recently developed a novel technology, called LIPSTIC (labeling of immune partnership by SorTagging intercellular contacts), that allows for identifying cells undergoing specific interactions thanks to an enzymatic labeling reaction. Our work demonstrated the use of this technology to monitor interactions between immune cells, both in vitro and in vivo, by the genetic engineering of CD40 and CD40L, an essential costimulatory axis between antigen-presenting cells and T cells. Here we describe protocols to design novel LIPSTIC-engineered ligand and receptor pairs, clone constructs into retroviral expression vector, perform their initial validation, and use them to measure interactions ex vivo. This information will be useful to investigators interested in exploiting the LIPSTIC technology to track their favorite immune interaction. Basic Protocol 1: Design of LIPSTIC-engineered ligand and receptor pairs Basic Protocol 2: Cloning of LIPSTIC-engineered ligand and receptor pairs Basic Protocol 3: Validation of LIPSTIC-engineered ligand and receptor pairs in 293T cells Basic Protocol 4: Measuring interaction with LIPSTIC in immune cells ex vivo 2021-12-01 /pmc/articles/PMC7613713/ /pubmed/34870906 http://dx.doi.org/10.1002/cpz1.311 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Article
Alberti, Dafne
Guarniero, Michelle
Maciola, Agnieszka K.
Dotta, Enrico
Pasqual, Giulia
Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions
title Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions
title_full Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions
title_fullStr Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions
title_full_unstemmed Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions
title_short Engineering Ligand and Receptor Pairs with LIPSTIC to Track Cell-Cell Interactions
title_sort engineering ligand and receptor pairs with lipstic to track cell-cell interactions
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613713/
https://www.ncbi.nlm.nih.gov/pubmed/34870906
http://dx.doi.org/10.1002/cpz1.311
work_keys_str_mv AT albertidafne engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions
AT guarnieromichelle engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions
AT maciolaagnieszkak engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions
AT dottaenrico engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions
AT pasqualgiulia engineeringligandandreceptorpairswithlipstictotrackcellcellinteractions